Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 17, 2010
Optimal measurement model is crucial to identify distinct constructsPranav GandhiQuality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 29, 2010
In reply to: Association between utility and treatment among patients with prostate cancerPranav Gandhi, Joshua Spooner, I-Chan HuangClinical Lymphoma, Myeloma & Leukemia|June 7, 2024
Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the MolecularDanielle Brazel, David Hermel, Pranav Gandhi, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 29, 2020
Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and RaceByron J Hoogwerf, Michele MacKenzie, Whitney Sealls, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 12, 2019
Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular DiseaseMafalda Ramos, Volker Foos, Anastasia Ustyugova, et al.Headache|June 24, 2025
Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete-choice experimentRichard B Lipton, Pranav Gandhi, Kelley Myers, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 11, 2017
All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or WarfarinAdrienne M Gilligan, Pranav Gandhi, Xue Song, et al.Canadian Journal of Diabetes|March 28, 2021
Quantifying the Risk Continuum for Cardiovascular Death in Adults with Type 2 DiabetesBrent A Williams, James C Blankenship, Stephen Voyce, et al.Current Medical Research and Opinion|September 2, 2017
Cost-effectiveness analysis of dabigatran versus rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation using real-world evidence in elderly US Medicare beneficiariesSiyang Peng, Kristen A Deger, Anastasia Ustyugova, et al.American Journal of Clinical Pathology|October 15, 2013
Chronic myelomonocytic leukemia monocytes uniformly display a population of monocytes with CD11c underexpressionPayal Sojitra, Pranav Gandhi, Priscilla Fitting, et al.Pageof 3